IN2014DE00211A - - Google Patents

Download PDF

Info

Publication number
IN2014DE00211A
IN2014DE00211A IN211DE2014A IN2014DE00211A IN 2014DE00211 A IN2014DE00211 A IN 2014DE00211A IN 211DE2014 A IN211DE2014 A IN 211DE2014A IN 2014DE00211 A IN2014DE00211 A IN 2014DE00211A
Authority
IN
India
Prior art keywords
valsartan
preparation
pharmaceutically acceptable
acceptable salts
relates
Prior art date
Application number
Inventor
Ashutosh Agarwal
Sandeep Jain
Rajendra Singh Shekhawat
Dharam Vir
Original Assignee
Jubilant Lifesciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jubilant Lifesciences Ltd filed Critical Jubilant Lifesciences Ltd
Priority to IN211DE2014 priority Critical patent/IN2014DE00211A/en
Publication of IN2014DE00211A publication Critical patent/IN2014DE00211A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

This invention relates to an improved process for the preparation of valsartan and pharmaceutically acceptable salts thereof, which is simple, environment friendly, economically viable and industrially feasible.
IN211DE2014 2014-01-23 2014-01-23 IN2014DE00211A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN211DE2014 IN2014DE00211A (en) 2014-01-23 2014-01-23

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN211DE2014 IN2014DE00211A (en) 2014-01-23 2014-01-23

Publications (1)

Publication Number Publication Date
IN2014DE00211A true IN2014DE00211A (en) 2015-07-31

Family

ID=54393519

Family Applications (1)

Application Number Title Priority Date Filing Date
IN211DE2014 IN2014DE00211A (en) 2014-01-23 2014-01-23

Country Status (1)

Country Link
IN (1) IN2014DE00211A (en)

Similar Documents

Publication Publication Date Title
IN2014CH00247A (en)
MX2017006266A (en) Heteroaryl compounds as irak inhibitors and uses thereof.
EP3233141A4 (en) Generation of peroxyformic acid through polyhydric alcohol formate
TW201613853A (en) Synthesis of polycyclic-carbamoylpyridone compounds
MX2016011160A (en) Treatment of conditions associated with hyperinsulinaemia.
EP3166931A4 (en) An improved process for the preparation of enzalutamide
EP3148979A4 (en) Process for preparation of canagliflozin
EP3230280A4 (en) Process for preparation of luliconazole
IN2014MU00455A (en)
EP3149011A4 (en) Process of synthesizing diisopropylaminw-disilanes
IN2014MU00675A (en)
IL248267B (en) Process for the preparation of substituted cycloserines
PL3160985T3 (en) Process for the production of d-arginyl-2,6-dimethyl-l-tyrosyl-l-lysyl-l-phenylalaninamide
IN2014CH00304A (en)
NZ721832A (en) Solid forms of tenofovir
IN2013MU01290A (en)
EP3240575A4 (en) Co-crystal of carfilzomib with maleic acid and process for the preparation of pure carfilzomib
EP3145507A4 (en) Aza-ellipticine analogs, methods of synthesis and methods of treatment
MX2016016398A (en) Preparation of piperidine-4-carbothioamide.
EP3124510A4 (en) Method for obtaining random terpolymers derived from itaconic acid and aconitic acid, and/or the isomers thereof, and/or sodium alkenyl sulphonates, and use of the resulting product
MX2015011881A (en) Process for the preparation of 3,7-dimethylnonan-1-ol.
IN2014DE00211A (en)
IN2014CH01391A (en)
MX2017007510A (en) A process for the manufacture of idalopirdine.
MX2017004770A (en) Solid forms of nilotinib hydrochloride.